NCT06712355 Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06646276 A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS). Status RECRUITING Phase PHASE3
NCT06406465 A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity Status RECRUITING Phase PHASE2
NCT05389423 Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas Status RECRUITING Phase PHASE1
NCT04139304 A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma Status RECRUITING Phase EARLY_PHASE1
NCT03811002 Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00092222 Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity Status ACTIVE_NOT_RECRUITING Phase PHASE2